Therefore, development of KP analogues which activate kisspeptin receptor and resist or inhibit MMPs may provide a novel treatment to inhibit cancer cell metastasis or for hormone replacement therapies with enhanced potency. The gene discussed is KISS1R; the disease is cancer.